← Leaderboards
Eve Jelstrom
The Emmes Company, Llc
$42,013,348
Attributed
$42,013,348
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.8M · FY2021–25$20M$15M$10M$5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,013,348 · 2
By mechanism
N01$42,013,348 · 2
Top collaborators
No co-investigators on record.
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Darby Thompson$10,610,431
- Jennifer McCormack$25,403,412
- Robert Lindblad$59,748,609
- Paul Vanveldhuisen$63,018,753
- Traci E Clemons$15,192,293
Others in their field
Other Emerging Leaders on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$250,731,514
Research focus
United States National Institutes Of HealthHelping To End Addiction Long-TermOpiate AddictionOpioidPublic HealthOpioid MisuseSpeedClinical Trials NetworkContractsNational Institute Of Drug AbuseOpioid EpidemicSupport ContractsResourcesClinical ResearchConsultationsClinical InvestigatorMonitorLogisticsCommunity Based TreatmentHealth PersonnelGrantFundingClinical TrialsMulti-Institutional Clinical Trial
Grant awards (17)
TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29$1,707,498
N01 · FY2025 · DA · contact PI
CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27.$267,558
N01 · FY2025 · DA · contact PI
CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28$3,419,274
N01 · FY2024 · DA · contact PI
CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/2026$2,988,430
N01 · FY2024 · DA · contact PI
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN) HEAL STUDIES. POP 2/26/24 - 8/25/24$2,026,076
N01 · FY2024 · DA · contact PI
CTN CLINICAL COORDINATING CENTER TASK ORDER 8. POP 2/24/23 â 2/23/24$842,918
N01 · FY2024 · DA · contact PI
CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/25$463,233
N01 · FY2024 · DA · contact PI
CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27.$256,829
N01 · FY2024 · DA · contact PI
CTN CLINICAL COORDINATING CENTER TASK ORDER 9. POP 5/15/23 - 5/14/24.$5,989,270
N01 · FY2023 · DA · contact PI
CTN CLINICAL COORDINATING CENTER TASK ORDER 8. POP 2/24/23 â 2/23/24$4,108,286
N01 · FY2023 · DA · contact PI
FY23. TO 10 - CTN CLINICAL COORDINATING CENTER - CTN-0144. PERIOD OF PERFORMANCE: SEPTEMBER 7, 2023, TO DECEMBER 31, 2027$990,350
N01 · FY2023 · DA · contact PI
FY23. CTN CLINICAL COORDINATING CENTER TASK ORDER 12. SEPTEMBER 15, 2023 TO SEPTEMBER 14, 2028.$796,913
N01 · FY2023 · DA · contact PI
FY23. TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/24.$241,539
N01 · FY2023 · DA · contact PI
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)$6,800,120
N01 · FY2022 · DA · contact PI
EXERCISE THE OPTION ITEM UNDER THE CLINICAL TRIALS NETWORK CLINICAL COORDINATING CENTER. JULY 6, 2022 - JULY 5, 2023. TASK ORDER 6$4,683,571
N01 · FY2022 · DA · contact PI
MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTINGS. FY22. POP 9/15/22 - 9/14/27.$1,299,926
N01 · FY2022 · DA · contact PI
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)$5,131,557
N01 · FY2021 · DA · contact PI